These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 1543196)
1. Increased soluble CD4 and decreased soluble CD8 molecules in patients with Sjögren's syndrome. Sawada S; Sugai S; Iijima S; Takei M; Paredes E; Hayama T; Nishinarita S; Hosokawa Y; Horie T; Obara T Am J Med; 1992 Feb; 92(2):134-40. PubMed ID: 1543196 [TBL] [Abstract][Full Text] [Related]
2. Immunologic significance of increased soluble CD8/CD4 molecules in patients with active systemic lupus erythematosus. Sawada S; Hashimoto H; Iijima S; Tokano Y; Takei M; Shida M; Obara T J Clin Lab Anal; 1993; 7(3):141-6. PubMed ID: 8509943 [TBL] [Abstract][Full Text] [Related]
3. Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study. Spronk PE; ter Borg EJ; Huitema MG; Limburg PC; Kallenberg CG Ann Rheum Dis; 1994 Apr; 53(4):235-9. PubMed ID: 8203951 [TBL] [Abstract][Full Text] [Related]
4. Increased levels of soluble CD8 and CD4 in patients with infectious mononucleosis. Yoneyama A; Nakahara K; Higashihara M; Kurokawa K Br J Haematol; 1995 Jan; 89(1):47-54. PubMed ID: 7833276 [TBL] [Abstract][Full Text] [Related]
5. Changes in soluble CD4 and CD8 proteins in healthy pregnant and postpartum women. Watanabe M; Iwatani Y; Hidaka Y; Mitsuda N; Amino N Am J Reprod Immunol; 1996 Oct; 36(4):220-7. PubMed ID: 8911630 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to CD4 in primary Sjögren's syndrome. Henriksson G; Manthorpe R; Bredberg A Rheumatology (Oxford); 2000 Feb; 39(2):142-7. PubMed ID: 10725063 [TBL] [Abstract][Full Text] [Related]
7. Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis. Hebbar M; Jeannin P; Magistrelli G; Hatron PY; Hachulla E; Devulder B; Bonnefoy JY; Delneste Y Clin Exp Immunol; 2004 May; 136(2):388-92. PubMed ID: 15086406 [TBL] [Abstract][Full Text] [Related]
8. Serum soluble Fas/APO-1 is increased in patients with primary Sjögren's syndrome. Fujihara T; Takeuchi T; Tsubota K; Kayagaki N; Yagita H; Okumura K; Abe T Clin Rheumatol; 1998; 17(6):496-9. PubMed ID: 9890678 [TBL] [Abstract][Full Text] [Related]
9. Behavior of serum soluble interleukin-2 receptor, soluble CD8 and soluble CD4 in the early phases of acute pancreatitis. Pezzilli R; Billi P; Gullo L; Beltrandi E; Maldini M; Mancini R; Incorvaia L; Miglioli M Digestion; 1994; 55(4):268-73. PubMed ID: 8063032 [TBL] [Abstract][Full Text] [Related]
10. Increased frequency of CCR7 Wu C; Yang P; Liu H; Xiao W; Zhao L Cytokine; 2018 Oct; 110():9-17. PubMed ID: 29684636 [TBL] [Abstract][Full Text] [Related]
11. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis. Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764 [TBL] [Abstract][Full Text] [Related]
12. Soluble CD4 and CD8 molecules in patients with systemic sclerosis. Tokano Y; Kaneko H; Obara T; Hashimoto H; Okumura K; Hirose S Clin Rheumatol; 1993 Dec; 12(4):490-3. PubMed ID: 8124911 [TBL] [Abstract][Full Text] [Related]
13. Soluble CD4 and CD8 in serum from patients with localized scleroderma. Sato S; Fujimoto M; Kikuchi K; Ihn H; Tamaki K; Takehara K Arch Dermatol Res; 1996 Jun; 288(7):358-62. PubMed ID: 8818182 [TBL] [Abstract][Full Text] [Related]